Syneos Health, Inc. - FORM 10-K - EX-23.1 - EX-23.1 CONSENT OF DELOITTE & TOUCHE LLP - February 19, 2020

Attached files

file filename
EX-32.2 - EX-32.2 SECTION 906 CFO CERTIFICATION - Syneos Health, Inc.exhibit322section906cf.htm
EX-32.1 - EX-32.1 SECTION 906 CEO CERTIFICATION - Syneos Health, Inc.exhibit321section906ce.htm
EX-31.2 - EX-31.2 SECTION 302 CFO CERTIFICATION - Syneos Health, Inc.exhibit312section302cf.htm
EX-31.1 - EX-31.1 SECTION 302 CEO CERTIFICATION - Syneos Health, Inc.exhibit311section302ce.htm
EX-21.1 - EX-21.1 SIGNIFICANT SUBSIDIARIES OF THE REGISTRANT - Syneos Health, Inc.exhibit211significants.htm
EX-10.19.8 - EX-10.19.8 OMNIBUS AMENDMENT - Syneos Health, Inc.exhibit10198omnibusame.htm
EX-10.4.4 - EX-10.4.4 AMENDMENT TWO EXECUTIVE SERVICE AGREEMENT - Syneos Health, Inc.exhibit1044amendmenttw.htm
EX-10.8 - EX-10.8 LETTER AGREEMENT PAUL COLVIN - Syneos Health, Inc.exhibit108paulcolvin.htm
EX-10.7 - EX-10.7 LETTER AGREEMENT MICHELLE KEEFE - Syneos Health, Inc.exhibit107michellekeefe.htm
EX-10.3 - EX-10.3 MANAGEMENT INCENTIVE PLAN - Syneos Health, Inc.exhibit103mip.htm
EX-4.4 - EX-4.4 DESCRIPTION OF CAPITAL STOCK - Syneos Health, Inc.exhibit44capitalstock.htm
10-K - 10-K - Syneos Health, Inc.synh-20191231.htm

Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the incorporation by reference in Registration Statement Nos. 333-225459, 333-219607, 333-212154, and 333-199960 on Forms S-8, and Nos. 333-228559 and 333-208286 on Forms S-3 of our reports dated February 19, 2020, relating to the financial statements of Syneos Health, Inc. and the effectiveness of Syneos Health, Inc.’s internal control over financial reporting appearing in this Annual Report on Form 10-K for the year ended December 31, 2019.

/s/ Deloitte & Touche LLP

Raleigh, North Carolina
February 19, 2020


Syneos Health, Inc. Reports